[Pharmacological modulation of the appetite].
The hypothalamus plays an essential role in the regulation of the body weight of all living creatures. In it there is a convergence of signals from the nervous system and signals from the peripheral tissues, through a complex system of neurotransmitters and neuropeptides. The ever increasing understanding of this field, opens up new therapeutic possibilities, both current and future, in the treatment of eating disorders.
Cuerda Compés
M
M
Sección de Nutrición Clínica y Dietética, H.G.U. Gregorio Marañón, Madrid, España.
Bretón Lesmes
I
I
Camblor Alvarez
M
M
García Peris
P
P
D000273:Adipose Tissue; D001067:Appetite Depressants / Q000494:pharmacology / Q000627:therapeutic use*; D019167:Appetite Stimulants / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D013759:Dronabinol / Q000494:pharmacology / Q000627:therapeutic use; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D020738:Leptin; D019290:Megestrol Acetate / Q000494:pharmacology / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D011506:Proteins / Q000494:pharmacology / Q000627:therapeutic use
D001067:Appetite Depressants; D019167:Appetite Stimulants; D020738:Leptin; D011506:Proteins; D013759:Dronabinol; D019290:Megestrol Acetate
Modulación farmacológica del apetito.